TY - JOUR
T1 - Current status and future prospects of pathophysiology-based neuroprotective drugs for the treatment of vascular dementia
AU - Sinha, Kusum
AU - Sun, Chichun
AU - Kamari, Rashmi
AU - Bettermann, Kerstin
N1 - Funding Information:
This review study is financially supported by Clayco foundation (Grant# 900279HY1940 ).
Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/4
Y1 - 2020/4
N2 - Vascular dementia (VaD) is a progressive neurocognitive clinical syndrome that is caused by a decrease in cerebral blood flow and damage to the neurovascular unit. Given increasing life expectancy, VaD is emerging as one of the leading health problems in society. Despite the high global prevalence of cognitive impairment associated with VaD, diagnosis and treatment still remain limited because of the complexity of mechanisms of neuronal loss. Therefore, advances in our understanding of the pathophysiological mechanisms involved is crucial for the development of new therapeutic strategies. In this review, we highlight the pathophysiology, current pharmacology-based primary and secondary prevention strategies and emerging treatment options for VaD.
AB - Vascular dementia (VaD) is a progressive neurocognitive clinical syndrome that is caused by a decrease in cerebral blood flow and damage to the neurovascular unit. Given increasing life expectancy, VaD is emerging as one of the leading health problems in society. Despite the high global prevalence of cognitive impairment associated with VaD, diagnosis and treatment still remain limited because of the complexity of mechanisms of neuronal loss. Therefore, advances in our understanding of the pathophysiological mechanisms involved is crucial for the development of new therapeutic strategies. In this review, we highlight the pathophysiology, current pharmacology-based primary and secondary prevention strategies and emerging treatment options for VaD.
UR - http://www.scopus.com/inward/record.url?scp=85078742707&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078742707&partnerID=8YFLogxK
U2 - 10.1016/j.drudis.2020.01.003
DO - 10.1016/j.drudis.2020.01.003
M3 - Review article
C2 - 31981482
AN - SCOPUS:85078742707
VL - 25
SP - 793
EP - 799
JO - Drug Discovery Today
JF - Drug Discovery Today
SN - 1359-6446
IS - 4
ER -